(Q36395126)

13 August 2017

1 reference

title

Active surveillance with selective delayed intervention is the way to manage 'good-risk' prostate cancer (English)

1 reference

13 August 2017

1 reference

1

Laurence Klotz

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

13 August 2017

published in

Nature Reviews Urology

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

136-42; quiz 1 p following 149

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpuro0124

13 August 2017

exact match

0 references

cites work

The influence of finasteride on the development of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Prostate biopsy: how many cores are enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Natural history of progression after PSA elevation following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Natural History of Early, Localized Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Active surveillance: towards a new paradigm in the management of early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Watchful waiting or watchful progression?: Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Observations of prostate specific antigen doubling time in Japanese patients with nonmetastatic prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

The role of serial free/total prostate-specific antigen ratios in a watchful observation protocol for men with localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Quality of life after radical prostatectomy or watchful waiting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Active monitoring (deferred treatment or watchful waiting) in the treatment of prostate cancer. A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Natural history of localised prostatic cancer managed by conservative therapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Cancer statistics, 1993

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Age and racial distribution of prostatic intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

The role of watchful waiting in the management of localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Active surveillance: an individualized approach to early prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

PSA doubling time of prostate carcinoma managed with watchful observation alone

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Correlation of pathologic findings with progression after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Insignificant Prostate Cancer in Radical Prostatectomy Specimen: Time Trends and Preoperative Prediction

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Use of pretreatment prostate-specific antigen doubling time to predict outcome after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Serial prostate specific antigen measurements and progression in untreated confined (stages T0 to 3NxM0, grades 1 to 3) carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

The dynamics of prostate specific antigen during watchful waiting of prostate carcinoma: a study of 94 Japanese men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Carcinoma of the prostate: a 15-year followup

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

The risk of dying of prostate cancer in patients with clinically localized disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Deferred treatment for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Prognosis of localised prostatic cancer managed by "watch and wait" policy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Expectant management of localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0124

7 January 2021

Identifiers

DOI

10.1038/NCPURO0124

1 reference

Dimensions Publication ID

13 August 2017

1002162191

0 references

1 reference